Fig. 3From: The role of stromal immune microenvironment in the progression of ductal carcinoma in situ (DCIS) to invasive breast cancerThe differences in the scores of CD138 + immune cells in the group of 30 patients with primary DCIS and in 11 patients with primary DCIS without local recurrence (p < 0.001)Back to article page